https://www.bloomberg.com/news/articles/2026-06-17/biontech-investor-fortsch-says-founders-spinout-r

UBS analyst David Dai upgrades BioNTech (NASDAQ:BNTX) from Neutral to Buy and raises the price ta

Bernstein analyst Jeffrey Walch initiates coverage on BioNTech (NASDAQ:BNTX) with a Market Perfor

Canaccord Genuity analyst John Newman maintains BioNTech (NASDAQ:BNTX) with a Buy and lowers the

Wells Fargo analyst Mohit Bansal maintains BioNTech (NASDAQ:BNTX) with a Overweight and lowers th

https://www.nytimes.com/2026/05/05/us/politics/fda-covid-vaccine-studies.html

BioNTech shares fall after Q1 revenue miss and wider net loss, despite lower-than-expected loss and

BioNTech (NASDAQ:BNTX) affirms FY2026 sales outlook from $2.328 billion-$2.678 billion to $2.328 bil

BioNTech (NASDAQ:BNTX) reported quarterly losses of $(2.28) per share which beat the analyst consens

US stock futures mixed, SanDisk (NASDAQ: SNDK) shares drop 5.6% in pre-market following strong Q3 re

HC Wainwright & Co. analyst Robert Burns reiterates BioNTech (NASDAQ:BNTX) with a Buy and mai

Elon Musk raises concerns over COVID-19 vaccine dosage, citing a severe reaction that nearly led to

Trastuzumab pamirtecan, an investigational HER2-targeted antibody-drug conjugate, met the primary ef

Pfizer Inc (NYSE:PFE) shares are trading lower on Tuesday after the company and its COVID-19 vaccine

Pfizer & BioNTech halt recruitment for a major U.S. COVID vaccine trial for adults 50–64 due to

Vaccine makers Pfizer PFE.N and BioNTech 22UAy.DE have halted recruitment for a large U.S. trial of

HC Wainwright & Co. analyst Robert Burns maintains BioNTech (NASDAQ:BNTX) with a Buy and lowe

Presentations showcase progress in BioNTech's late-stage lung cancer programs, reinforcing the p

Morgan Stanley analyst Terence Flynn maintains BioNTech (NASDAQ:BNTX) with a Overweight and lower

Citigroup analyst Geoff Meacham maintains BioNTech (NASDAQ:BNTX) with a Buy and lowers the price

BioNTech (BNTX) reported upbeat Q4 results and FY26 sales guidance below estimates. Shares gained 7.

TD Cowen analyst Yaron Werber maintains BioNTech (NASDAQ:BNTX) with a Hold and lowers the price t

Dow falls 200+ points as Serve Robotics Inc (NASDAQ: SERV) shares rise 16.2% on better-than-expected

BMO Capital analyst Etzer Darout maintains BioNTech (NASDAQ:BNTX) with a Outperform and lowers th

Jefferies analyst Akash Tewari maintains BioNTech (NASDAQ:BNTX) with a Buy and lowers the price t

BioNTech stock tumbled Tuesday as investors digested new questions. Here's what execs said on th

US stocks rise with Dow up over 300 points, S&P 500 and NASDAQ also gaining. Kohl's Corp sha

US stocks mixed, Dow down 0.1%, NASDAQ up 0.13%, S&P 500 down 0.08%. Materials sector up, utilit

BioNTech stock falls in premarket trading after co-founders announce plans to launch a new mRNA vent

US stock futures lower, FreightCar America (RAIL) plunges after weak earnings. Other stocks moving l

BioNTech (NASDAQ:BNTX) reported quarterly losses of $(0.38) per share which beat the analyst consens

BioNTech continues to sharpen its strategic focus on the growing late-stage clinical pipeline spanni

Investors are anticipating earnings releases from Oracle, Ulta, Adobe, Dick's, AeroVironment and

Moderna shares jump after a $950 million settlement over COVID-19 vaccine patents, easing investor c

Ten large-cap stocks led last week's gains, driven by upbeat earnings, guidance, buybacks, and k

BioNTech has sued Moderna, alleging its mNEXSPIKE vaccine uses patented COVID vaccine technology wit

Earnings misses, weak guidance, and downgrades drove large-cap decliners—led by Synopsys, Chewy, and

Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. is pledging a major overhaul of the